Recombinant multi-species CUL3/CUL-3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CUL3/CUL-3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the cullin protein family. The encoded protein plays a critical role in the polyubiquitination and subsequent degradation of specific protein substrates as the core component and scaffold protein of an E3 ubiquitin ligase complex. Complexes including the encoded protein may also play a role in late endosome maturation. Mutations in this gene are a cause of type 2E pseudohypoaldosteronism. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Mar 2012]
The Alternative Names of target: CUL-3,CUL3,Cul3,Cullin-3,KIAA0617,NEDAUS,PHA2E,cullin-3
Go
to CUL3/CUL-3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T04364-Ag-1/ GM-Tg-hg-T04364-Ag-2 | Human CUL3/CUL-3 protein | Human |
| GM-Tg-rg-T04364-Ag-1/ GM-Tg-rg-T04364-Ag-2 | Rat CUL3/CUL-3 protein | Rat |
| GM-Tg-mg-T04364-Ag-1/ GM-Tg-mg-T04364-Ag-2 | Mouse CUL3/CUL-3 protein | Mouse |
| GM-Tg-cynog-T04364-Ag-1/ GM-Tg-cynog-T04364-Ag-2 | Cynomolgus/Rhesus macaque CUL3/CUL-3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T04364-Ag-1/ GM-Tg-felg-T04364-Ag-2 | Feline CUL3/CUL-3 protein | Feline |
| GM-Tg-cang-T04364-Ag-1/ GM-Tg-cang-T04364-Ag-2 | Canine CUL3/CUL-3 protein | Canine |
| GM-Tg-bovg-T04364-Ag-1/ GM-Tg-bovg-T04364-Ag-2 | Bovine CUL3/CUL-3 protein | Bovine |
| GM-Tg-equg-T04364-Ag-1/ GM-Tg-equg-T04364-Ag-2 | Equine CUL3/CUL-3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T04364-Ag-1/ GM-Tg-hg-T04364-Ag-2;
GM-Tg-rg-T04364-Ag-1/ GM-Tg-rg-T04364-Ag-2;
GM-Tg-mg-T04364-Ag-1/ GM-Tg-mg-T04364-Ag-2; GM-Tg-cynog-T04364-Ag-1/ GM-Tg-cynog-T04364-Ag-2; GM-Tg-felg-T04364-Ag-1/ GM-Tg-felg-T04364-Ag-2; GM-Tg-cang-T04364-Ag-1/ GM-Tg-cang-T04364-Ag-2; GM-Tg-bovg-T04364-Ag-1/ GM-Tg-bovg-T04364-Ag-2; GM-Tg-equg-T04364-Ag-1/ GM-Tg-equg-T04364-Ag-2 |
| Products Name | CUL3/CUL-3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CUL3/CUL-3 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CUL3/CUL-3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.